(Q45735907)

15 December 2017

title

Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients (English)

1 reference

15 December 2017

0 references

1 reference

1 reference

1 reference

Sennesael JJ

1

1 reference

15 December 2017

Van der Niepen P

series ordinal

2

1 reference

15 December 2017

Verbeelen DL

series ordinal

3

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 July 1991

1 reference

15 December 2017

1 reference

15 December 2017

volume

40

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

121-128

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1991.189

15 December 2017

exact match

0 references

cites work

Host defenses and immunologic alterations associated with chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Causes of Death in Patients Receiving Long-Term Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Tuberculosis in patients undergoing maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

IMMUNOLOGIC STUDIES IN HUMAN ORGAN TRANSPLANTATION. I. OBSERVATION AND CHARACTERIZATION OF SUPPRESSED CUTANEOUS REACTIVITY IN UREMIA

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Prolonged survival of skin homografts in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Active hepatitis B vaccination of dialysis patients and medical staff

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

The effect of uremia and transplantation on lymphocyte subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Analysis of immune status of hemodialyzed adults: Association with prior transfusions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Suppressor cells assayed by numerical and functional tests in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

The Role of Monocytes and Responder Cells in Suppression of Antigen-Specific T Cell Proliferation in Chronic Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Suppressor cells in end-stage renal disease. Functional assays and monoclonal antibody analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Factors influencing the response to hepatitis B vaccination of hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Lymphocyte Subsets and Delayed Cutaneous Hypersensitivity in Hemodialysis Patients Receiving Recombinant Human Erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Immunogenicity of recombinant hepatitis B vaccine in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

[Vaccination of uremic patients against hepatitis B]

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Suppressive Effect of Ferritin on in Vitro Lymphocyte Function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

T cell subsets and cellular immunity in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Suppressor Cells and Immunoregulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Diurnal variation of lymphocyte subsets identified by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Large-amplitude circadian rhythm in helper:suppressor ratio of peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Effect of hemodialysis on T lymphocyte subsets, con-A-activated suppressor cell activity, and interleukin-2 receptor expression on lymphocytes in chronic uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Suppression of lymphocyte reactivity by blood transfusions in uremic patients. I. Proliferative responses

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Suppression of lymphocyte reactivity by blood transfusions in uremic patients. III. Regulation of cell-mediated lympholysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.189

7 January 2021

Identifiers

DOI

10.1038/KI.1991.189

1 reference

Dimensions Publication ID

15 December 2017

1047112925

0 references

1 reference